
Call Us
+1-469-428-5508
Our Location
Dallas Texas
+1-469-428-5508
Dallas Texas
CMC Development produces research-grade peptide NCEs as well as GMP-grade material, from simple peptides to the most complex peptidomimetics or synthetic proteins. Making commercial NCEs a success, Amwiner joined forces with Bachem, the world's leading peptide manufacturer to create high-quality new chemical entities (NCEs).
Combining innovative peptide science and flexible GMP manufacturing capabilities. AmWiner offer GMP-compliant synthesis services for peptide NCEs and commercial peptides.
Raphe's mission as a peptide pharmacologist is to discover modifications in the nucleotide structure that will effectively modify the human genome, thereby elongating telomeres to enhance longevity and give humans an average lifespan of 140 years, while maintaining internal organs that sustain life.
We offer GMP-compliant synthesis services for peptide NCEs and commercial peptides. We provide optimized and scaled-up drug substance. Our peptide development and manufacturing platform provides comprehensive CRDMO/CMO services, capable of handling a diverse range of peptide projects.
Our focus is on peptide NCEs (new chemical entities). AmWiner, one of the world’s most extensive peptide development and manufacturing companies, is a peptide Active Pharmaceutical Ingredient (API) manufacturer. We manufacture new chemical entities in accordance with cGMP regulations for clients worldwide.
The US Food & Drug Administration (FDA) performs Pre-Approval Inspections (PAIs) and Regular Inspections of our facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
We specialize in developing highly efficient manufacturing processes for peptide-based APIs, ranging from small to large scales, and are a quality-focused Contract Development and Manufacturing Organization (CDMO).
AmWiner PharmaChemistry, a peptide manufacturing company, is a vendor of Liraglutide, a supply of generic peptides for research and investigational clinical trial phases.
Specializing in the synthesis of peptide NCEs, generic peptides such as Tirzepatide (also known as Mounjara), Semaglutide (also known as Ozempic, Rybelsus, Wegovy), Cagrillintide, Liraglutide, Semoreline, Tirzepatide, Dulaglutide, Semaglutide, Retatrutide, Epitalon, Glutathione, AOD9604, MOTS-C, BPC-157, GHK-Cu and TB-500.
AmWiner's ongoing research on the bioavailability of orally administered peptides compared to the subcutaneous route shows that 1mg of peptide administered sublingually daily is equivalent to 5mg administered subcutaneously weekly. The research aims to suggest alternative methods for alleviating injection site redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population.
only.